| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.22 | 9e-11 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.31 | 5e-09 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-09 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-08 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-08 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-07 |